Patients & Visitors ›

Profile

Profile
Research

Richard P. McQuellon, Ph.D.

Professor, Hematology & Oncology
Comprehensive Cancer Center
Center for Integrative Medicine
Family & Community Medicine
Psychiatry and Behavioral Medicine

Clinical Specialties

Psychosocial Oncology, Quality of Life, Depression in Cancer Patients

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-5440
Department: 336-716-4464

Email: rmcquell@wakehealth.edu

Education & Training

Ph.D., Michigan State University , 1983
B.S., University of Washington , 1971
M.A., Appalachian State University , 1974
Internship, Psychology, Ingham Medical Center, 1983

Memberships

Am Assn Of Marriage & Family T
Am Psychological Assn
Am Soc Of Hypertension
Canadian Society For Immunolog
Eastern Gut Club
Forsyth Co. Psychological Soci

NPI Number

1275518623

Richard P. McQuellon, Ph.D.

Professor, Hematology & Oncology Comprehensive Cancer Center
Center for Integrative Medicine
Family & Community Medicine
Psychiatry and Behavioral Medicine

Contact Information

Academic: 336-716-7980 | Department: 336-716-4464

Email: rmcquell@wakehealth.edu

Recent Publications

Addington E, Russell G, Tedeschi R, Levine E, Shen P, Stewart J, Danhauer S, Duckworth K, McQuellon R. Post-traumatic growth is sustained two years after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy [abstract]. Psychooncology. 2013;22(Suppl 2):54.

Duckworth K, Forti A, Russell G, Campbell C, Naik S, Hurd D, McQuellon R. Advance care planning information and distress in hematopoietic cell transplant candidates and proxies [abstract]. Psychooncology. 2013;22(Suppl 2):100-101.

Williams A, Winford E, Addington E, Scott T, Mcquellon R. Survivorship programming in an academic medical center [abstract]. Psychooncology. 2013;22(Suppl 2):123-124.

Ruiz J, Case D, Enevold G, Rosdhal R, Tatter SB, Ellis TL, McQuellon RP, McMullen KP, Stieber VW, Shaw EG, Lesser GJ. A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas. J Neurooncol. 2012;106(3):611-617.

Groleau J, Horn G, Campbell C, McQuellon R. Inpatient consultation with cancer patients: a guide for oncology counselors [abstract]. Psychooncology. 2012;21(Suppl 1):44.

McQuellon R, Duckworth K, Russell G, Shen P, Stewart J, Votanopoulos K, Levine E. After screening for depression in a high risk medical population: then what? [abstract]. Psychooncology. 2012;21(Suppl 1):126-127.

McQuellon R, Duckworth K, Campbell C, Russell G, Naik S, Levitan D, Zamkoff K, McQuellon BT, Hurd D. Fear of recurrence following hematopoetic stem cell transplantation [abstract]. Psychooncology. 2012;21(Suppl 1):127.

Chase DM, Huang HQ, Wenzel L, Cella D, McQuellon R, Long HJ, Moore DH, Monk BJ. Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2012;125(2):315-319.

Duckworth KE, McQuellon RP, Russell GB, Cashwell CS, Shen P, Stewart JH IV, Levine EA. Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC). J Surg Oncol. 2012;106(4):376-380.

Ihemelandu CU, Shen P, Stewart JH, Votanopoulos K, McQuellon R, Russell G, Levine EA. Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS plus HIPEC) with preoperative FACT - C (Functional Assessment of Cancer Therapy) and patient rated performance status [abstract]. Ann Surg Oncol. 2012;19(Suppl 1):S16.

McQuellon R, Horn G, Campbell C, Duckworth K. Fee-for-service payment for counseling in a comprehensive cancer center [abstract]. Psychooncology. 2011;20(Suppl 1):17-18.

Duckworth K, McQuellon R, Russell G, Levine E, Shen P, Stewart J, Cromer M, Cashwell C. Quality of life and sleep quality of long-term survivors of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy [abstract]. Psychooncology. 2011;20(Suppl 1):79-80.

Campbell C, McQuellon R, Duckworth K, Russell G, Hurd D, Levitan D, Naik S, Zamkoff K, McQuellon B, Sommer J. Health related quality of life, depressive symptoms and distress before and after hematopoietic cell transplantation [abstract]. Psychooncology. 2011;20(Suppl 1):81.

Hill AR, McQuellon RP, Russell GB, Shen P, Stewart JH IV, Levine EA. Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin. Ann Surg Oncol. 2011;18(13):3673-3679.

McQuellon R, Campbell C, Russell G, Duckworth K, Sommer J, McQuellon B, Hurd D. Quality of survivorship, surveillance behavior and treatment satisfaction following hematopoietic cell transplantation [abstract]. Psychooncology. 2010;19(Suppl 1):S98-S99.

Horn G, Campbell C, Cangin M, Duckworth K, McQuellon R. The role of the oncology counselor in cancer interdisciplinary team meetings [abstract]. Psychooncology. 2010;19(Suppl 1):S65.

Yi JC, Syrjala KL, Abrams JR, Silver S, Tierney DK, Matous J, Wingard JR, Dansey R, McQuellon R, Langer SL. Multi-site study of caregiver outcomes during hemtopoietic cell transplantation (HCT) [abstract]. Ann Behav Med. 2010;39(Suppl 1):s201.

McQuellon RP, Cowan MA. In: The art of conversation through serious illness: lessons for caregivers. New York: Oxford University Press;2010: .

Hill AR, McQuellon RP, Russell GB, Shen P, Stewart JH, Levine EA. Survival and health-related quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for disseminated peritoneal cancer of colonic origin [abstract]. Ann Surg Oncol. 2010;17(Suppl 1):S9.

Blackstock AW, Aklilu M, Lovato J, Degrass L, Sommer J, Howerton R, Mishra G, Levine E, McQuellon R. Aprepitant/5HT-3 antagonist (EMEND) for the prevention of chemoradiation-induced nausea and vomiting (CRINV) in patients receiving gemcitabine/5-FU-based chemoradiation and concurrent upper abdominal radiation for pancreatic cancer [abstract]. J Clin Oncol. 2009;27(Suppl):e20661.

McQuellon R, Campbell C, Cangin M, Horn G, Duckworth K. Integrating psychosocial care and research in a comprehensive cancer center [abstract]. Psychooncology. 2009;18(Suppl 1):S42.

McQuellon R, Russell G, Campbell C, Duckworth K, Shen P, Stewart J, Fenstermaker J, Pruitt L, Cromer M, Levine E, et al. Assessing depressive symptoms with the Center for Epidemiologic Studies Depression Scale prior to cytoreductive surgery + intraperitoneal hyperthermic chemotherapy [abstract]. Psychooncology. 2009;18(Suppl 1):S42-S43.

McClure White G, Campbell C, Russell G, Duckworth K, Hurd D, McQuellon R. Assessing distress and depression in hematopoietic stem cell transplant patients [abstract]. Psychooncology. 2009;18(Suppl 1):S43.

McQuellon RP, Andrykowski M. Psychosocial issues in hematopoietic cell transplantation In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds. Thomas' hematopoietic cell transplantation: stem cell transplantation. 4th ed. Oxford (UK): Wiley-Blackwell;2009: 488-501.

McQuellon R, Duckworth KE. Health-related quality of life and cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Curr Probl Cancer. 2009;33(3):203-218.

McQuellon RP, Russell GB, Shen P, Stewart JH IV, Saunders W, Levine EA. Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin. Ann Surg Oncol. 2008;15(1):125-133.

McQuellon R, Gavazzi C, Piso P, Swain D, Levine E. Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): recommendations for care. J Surg Oncol. 2008;98(4):300-305.

Danhauer SC, Russell G, Campbell CR, Daley KL, McQuellon RP, Levine E. Restorative yoga for women with breast cancer: findings from a randomized pilot study [abstract]. Ann Behav Med. 2008;35(Suppl 1):S103.

Danhauer SC, Tooze JA, Farmer DF, Campbell CR, McQuellon RP, Barrett R, Miller BE. Restorative yoga for women with ovarian or breast cancer: findings from a pilot study. J Soc Integr Oncol. 2008;6(2):47-58.

Lesser GJ, Case D, Ottery F, McQuellon R, Choksi JK, Sanders G, Rosdhal R, Shaw EG. A phase III randomized study comparing the effects of oxandrolone (Ox) and megestrol acetate (Meg) on lean body mass (LBM), weight (wt) and quality of life (QOL) in patients with solid tumors and weight loss receiving chemotherapy [abstract]. J Clin Oncol. 2008;26(15 Suppl Pt I):505s.

Danhauer SC, Marler B, Rutherford CA, Lovato JF, Asbury DY, McQuellon RP, Miller BE. Music or guided imagery for women undergoing colposcopy: a randomized controlled study of effects on anxiety, perceived pain, and patient satisfaction. J Low Genit Tract Dis. 2007;11(1):39-45.

McQuellon RP, Danhauer SC, Russell GB, Shen P, Fenstermaker J, Stewart JH, Levine EA. Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol. 2007;14(3):1105-1113.

Danhauer SC, Rutherford CA, Hurt G, Gentry S, Lovato J, McQuellon RP. Providing psychosocial group support for young women with breast cancer: findings from a wellness-based community collaboration. J Psychosoc Oncol. 2007;25(1):103-120.

McQuellon RP, Russell GB, Shen P, Stewart JH, Saunders WW, Levine EA. Survival and quality of life (QOL) after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy (IPHC) for disseminated peritoneal cancer (PC) of appendiceal origin [abstract]. Ann Surg Oncol. 2007;14(2 Suppl):30-31.

Molnar I, Stark N, Lovato J, Powell BL, Cruz J, Hurd DD, Mathieu JS, Cambra S, McQuellon RP, Schwartz GG, et al. Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D(3)) [letter]. Leukemia. 2007;21(5):1089-1092.

Hochhausen N, Altmaier EM, McQuellon R, Davies SM, Papadopolous E, Carter S, Henslee-Downey J. Social support, optimism, and self-efficacy predict physical and emotional well-being after bone marrow transplantation. J Psychosoc Oncol. 2007;25(1):87-101.

Butler JM Jr, Case LD, Frizzell B, Lesser G, McMullen K, McQuellon R, Naughton M, Rapp S, Stieber V, Shaw EG, et al. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2007;69(5):1496-1501.